Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Consumption of glaucoma medication.

B M Calissendorff1

  • 1St. Erik's Eye Hospital AB, Stockholm, Sweden.

Acta Ophthalmologica Scandinavica
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Glaucoma medication use is rising in Nordic countries, driven by more daily doses rather than just an aging population. Significant national and regional variations in drug consumption exist across Sweden and Denmark.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Costs of medical and surgical treatment of glaucoma.

Acta ophthalmologica Scandinavica·2001
Same author

Blindness in glaucoma patients.

Acta ophthalmologica Scandinavica·1998
Same author

Cataract development in adult bone marrow transplant recipients.

Acta ophthalmologica Scandinavica·1995
Same author

Intraocular pressure after extracapsular cataract extraction with implantation of posterior chamber lenses.

Acta ophthalmologica·1993
Same author

Cataract development and outcome of surgery in bone marrow transplanted children.

The British journal of ophthalmology·1993
Same author

Pressure control in glaucoma patients after cataract surgery with intraocular lens.

European journal of ophthalmology·1992
Same journal

Expression of interleukin-6, tumour necrosis factor-alpha and nitric oxides during episodes of ocular toxoplasmosis in an HIV patient.

Acta ophthalmologica Scandinavica·2007
Same journal

Varicella chorioretinitis.

Acta ophthalmologica Scandinavica·2007
Same journal

Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables.

Acta ophthalmologica Scandinavica·2007
Same journal

Solving the enigma of exfoliation glaucoma: a breakthrough in glaucoma research.

Acta ophthalmologica Scandinavica·2007
Same journal

Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up.

Acta ophthalmologica Scandinavica·2007
Same journal

Incidence and prevalence of pseudoexfoliation and open-angle glaucoma in northern Sweden: I. Baseline report.

Acta ophthalmologica Scandinavica·2007
See all related articles

Area of Science:

  • Ophthalmology
  • Pharmacoeconomics
  • Public Health

Background:

  • Antiglaucoma drug consumption has steadily increased in Nordic countries over recent decades.
  • Cost increases are partly attributed to newer, more expensive medications.
  • The rise in daily doses significantly outpaces population aging.

Purpose of the Study:

  • To analyze trends in antiglaucoma drug consumption in Nordic countries.
  • To investigate national and regional variations in medication use.
  • To understand prescribing patterns for intraocular pressure (IOP)-lowering drugs.

Main Methods:

  • Analysis of statistical data on antiglaucoma drug consumption.
  • Comparison of medication usage in daily defined doses (DDD) across Nordic countries.

Related Experiment Videos

  • Examination of national and regional differences in drug consumption patterns.

    • Main Results:

    • Glaucoma medication consumption shows a marked increase in Nordic nations.
    • Significant disparities in consumption exist, with Sweden consuming nearly three times more than Denmark per DDD.
    • Regional variations within countries show up to a two-fold difference in consumption.
    • Newer classes of IOP-lowering drugs have been rapidly adopted.
    • Adding new medications is more prevalent than switching therapies.

    Conclusions:

    • Glaucoma drug consumption trends indicate a substantial increase beyond population aging.
    • Prescribing practices and regional factors significantly influence medication use.
    • The rapid adoption of new drug classes and preference for adding therapy warrant further investigation.